La Roche-Posay has partnered with Macmillan Cancer Support to help raise vital funds to support people living with cancer in the UK.

After working for years to support people experiencing skin side effects from cancer treatment, La Roche Posay will now provide additional resources, expert advice and funds to support this cause.

La Roche-Posay is signalling its passion and determination to improve the experience of cancer patients by donating £250,000 per year to Macmillan Cancer Support, which could help the experts on the Macmillan Support Line deal with more than 13,000 calls and web enquiries from people who want questions answered, need practical or emotional support, or just want to chat.

By 2025, La Roche-Posay aims to educate 1 billion people around the world about the side effects of cancer treatments; train 1 million people in supportive care; and support 100,000 patients going through cancer treatment.

Karen Flavard-Jones, MD of L’Oreal Active Cosmetics Division UKI, says: “La Roche-Posay are proud to partner will Macmillan Cancer Support; their vital work supports cancer patients and their loved ones across the UK. Sadly, we know that many cancer patients today will not have access to specialist dermatologist advice to support with the skin side effects of cancer treatment. In some cases, these can be so severe that patients discontinue vital treatment. Together with Macmillan, we want to ignite a change in our nation’s understanding of these side effects and how they can be alleviated, to better support patients undergoing cancer treatment.”